These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37094365)

  • 21. Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis.
    Lee Y; Lui LMW; Brietzke E; Liao Y; Lu C; Ho R; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
    J Affect Disord; 2022 Jan; 296():514-521. PubMed ID: 34656039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence.
    Kim TW; Walley AY; Heeren TC; Patts GJ; Ventura AS; Lerner GB; Mauricio N; Saitz R
    J Subst Abuse Treat; 2017 Oct; 81():1-10. PubMed ID: 28847449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts.
    Bowles J; Mansoor M; Werb D; Kerr T; Bardwell G
    J Subst Use Addict Treat; 2024 Feb; 157():209185. PubMed ID: 37865289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
    Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
    Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study.
    Corser J; Palis H; Fleury M; Lamb J; Lock K; McDougall J; Mehta A; Newman C; Spence H; Buxton JA
    Harm Reduct J; 2022 May; 19(1):46. PubMed ID: 35590375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas - United States.
    Mack KA; Jones CM; Ballesteros MF
    MMWR Surveill Summ; 2017 Oct; 66(19):1-12. PubMed ID: 29049278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas-United States.
    Mack KA; Jones CM; Ballesteros MF
    Am J Transplant; 2017 Dec; 17(12):3241-3252. PubMed ID: 29145698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent changes in trends of opioid overdose deaths in North America.
    Imtiaz S; Shield KD; Fischer B; Elton-Marshall T; Sornpaisarn B; Probst C; Rehm J
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):66. PubMed ID: 32867799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study.
    Palis H; Xavier C; Dobrer S; Desai R; Sedgemore KO; Scow M; Lock K; Gan W; Slaunwhite A
    BMC Public Health; 2022 Nov; 22(1):2084. PubMed ID: 36380298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial-temporal trends in the risk of illicit drug toxicity death in British Columbia.
    Hu K; Klinkenberg B; Gan WQ; Slaunwhite AK
    BMC Public Health; 2022 Nov; 22(1):2121. PubMed ID: 36401244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of co-occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada.
    Keen C; Kinner SA; Young JT; Jang K; Gan W; Samji H; Zhao B; Krausz M; Slaunwhite A
    Addiction; 2022 Jan; 117(1):129-140. PubMed ID: 34033179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
    Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ecological study of the correlation between COVID-19 support payments and overdose events in British Columbia, Canada.
    Richardson L; Geddes C; Palis H; Buxton J; Slaunwhite A
    Int J Drug Policy; 2024 Apr; 126():104362. PubMed ID: 38484530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining prevalence and correlates of smoking opioids in British Columbia: opioids are more often smoked than injected.
    Parent S; Papamihali K; Graham B; Buxton JA
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):79. PubMed ID: 34663374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada.
    Krajden M; Cook DA; Wong S; Yu A; Butt ZA; Rossi C; Darvishian M; Alvarez M; Buxton JA; Tyndall M; Janjua NZ
    Int J Drug Policy; 2019 Oct; 72():114-122. PubMed ID: 31229445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada.
    Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810
    [No Abstract]   [Full Text] [Related]  

  • 39. A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States.
    Chiosi JJ; Mueller PP; Chhatwal J; Ciaranello AL
    BMC Health Serv Res; 2023 Jul; 23(1):760. PubMed ID: 37461007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis.
    Yarborough BJ; Stumbo SP; Janoff SL; Yarborough MT; McCarty D; Chilcoat HD; Coplan PM; Green CA
    Drug Alcohol Depend; 2016 Oct; 167():49-56. PubMed ID: 27520885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.